Home
Stonepine Capital Management reported a 4.3% stake in Aprea Therapeutics APRE · 239,416 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.3%
- Last report
- 5.1% · filed 25/02/13
- Shares held
- 239,416 sh
- Class
- Common Stock
- Event date
- 25/03/31
- Filed
- 25/05/14
4.3% stake · below 5%
- Stake
- 4.3%
- Last report
- 5.1%
- Since last report
- −0.8pp
Aprea Therapeutics trades, last 26 weeks
What else happened in Aprea Therapeutics around then
Filed or reported within 30 days of the trade day · 25/03/01~25/04/30Stonepine Capital Management's other 5% stake reports
- Stonepine Capital Management
5% stakeFemasys
5% stakeFemasys
FEMY
7.2% stake
625,000 sh
7.2% stake
Filed 08/31
- Stonepine Capital Management
5% stakeEdesa Biotech
5% stakeEdesa Biotech
EDSA
6.9% stake
953,739 sh
6.9% stake
Filed 08/26
- Stonepine Capital Management
5% stakeCalciMedica
5% stakeCalciMedica
CALC
6% stake
2,149,522 sh
6% stake
Filed 08/25
- Stonepine Capital Management
5% stakeAeon Biopharma
5% stakeAeon Biopharma
AEON
9.9% stake
6,892,682 sh
9.9% stake
Filed 07/21
- Stonepine Capital Management
5% stakePasithea Therapeutics
5% stakePasithea Therapeutics
KTTA
5.8% stake
1,952,550 sh
5.8% stake
Filed 06/23
